Xponance’s Axonics, Inc. Common Stock AXNX Stock Holding History

Xponance’s Portfolio AXNX Stock Details AXNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-3,341	Closed	-$233K	–	1476
2024 Q3	$233K	Buy	3,341 +110	+3%	+$7.54K	﹤0.01%	1178
2024 Q2	$217K	Buy	3,231 +225	+7%	+$15.2K	﹤0.01%	1157
2024 Q1	$207K	Buy	+3,006	New	+$203K	﹤0.01%	1186

Other funds holding AXNX

TCA

Taconic Capital Advisors New York $229M AUM 110.07% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Xponance's AXNX Position: Q4 2024 in Review

Xponance sold out of Axonics, Inc. Common Stock (AXNX) in Q4 2024, closing a stake of 3,341 shares — an estimated $233K sold.

Xponance first reported a position in AXNX in Q1 2024 and held it in 3 quarters. The position peaked at $233K in Q3 2024. 2 funds tracked by Wall St. Rank hold AXNX as of Q4 2024.

Xponance reported no remaining Axonics, Inc. Common Stock position as of Q4 2024 after selling out during the quarter.
Xponance sold 3,341 Axonics, Inc. Common Stock shares in Q4 2024, an estimated $233K.
Xponance first reported a position in Axonics, Inc. Common Stock in Q1 2024 and held it in 3 quarters.
Xponance's Axonics, Inc. Common Stock position peaked at $233K in Q3 2024.
2 funds tracked by Wall St. Rank held Axonics, Inc. Common Stock as of Q4 2024.

Based on Xponance's 13F filing for Q4 2024, filed 11 Feb 2025.